Explore Solutions for Combatting AMR

Through our expertise and strategic partnerships, we are pushing boundaries with next-generation technologies to improve workflow and drive confidence in patient results. Our gold-standard accuracy helps laboratories stay ahead of rising demands. Preview our solutions below.

Join our In-Booth Presentations

We’re bringing the best minds together to unlock the full potential of the latest scientific advances. See our schedule below for in-booth presentations, presented by Beckman Coulter and Cepheid.

Saturday 12 April | 10:40-10:55
Innovation and Sustainability
Presented by: Dr. Joachim Reischl, Vice President, External Innovation Diagnostics, Danaher Diagnostics, and Ephraim Tsalik, Vice President and Chief Scientific Officer — Infectious Diseases, Danaher Diagnostics

Saturday 12 April | 15:50-16:05
Use of multiplex PCR in General Practitioners offices: feasibility and medical impact assessment in a randomized prospective study in Germany
Presented by: Scientist Tobias Tuschscherer, University Hospital Leipzig, Germany

Sunday 13 April | 10:40-10:55
GBS Intrapartum testing: Clinical Impact on mothers and newborns
Presented by: Dr Najoua El Helali, Microbiologist, Maternity Referent and GBS Expert, Medical Manager of antimicrobial dosage, Hôpital Saint-Joseph/ Marie-Lannelongue, Paris

Sunday 13 April | 15:50-16:05
Microbiology Lab Automation
Presented by: Dr. Mahmoud Gargouri, Biologiste Medical Co-Responsible, Laboratoire BIOVSM-LAB

Expert Insights on Diagnostics and Antimicrobial Resistance

Date: Monday 14 April
Time: 13:30 – 15:30
Location: HALL 6
Chairpersons:

ESCMID-appointed Chair: Laurent Dortet, Professor, Hôpital de Bicêtre, Laboratoire de Bactériologie, Le Kremlin-Bicêtre, France

Cepheid-appointed Chair: Devasena Gnanashanmugam, Vice President, Medical Affairs, Cepheid, USA

Overview:

This expert session, featuring speakers from across Europe, Middle East and USA, will feature leading healthcare professionals sharing contemporary data and real-world experiences on current critical healthcare challenges, including challenges of circulating respiratory viruses as well as the increased risk antimicrobial resistance. Further it will highlight the importance of testing and emphasize the role of accurate diagnostics in ensuring appropriate antibiotics use and innovating patient management, infection control and antimicrobial stewardship together with considerations for Near-patient testing.

Symposium Program:

Urgency in Combating AMR: The Critical Role of Molecular and Rapid Diagnostics for Actionable Outcome
Pr. Alison Holmes
Director of the NIHR HPRU in Healthcare Associated Infections (HCAI) and Antimicrobial Resistance (AMR), Imperial College London, UK

Rapid Respiratory Testing: Experience of POC and laboratory molecular testing in a large teaching hospital Trust
Mr. Nick Machin
Consultant Virologist, Manchester University Foundation Trust, UK

The Kentucky Viral Hepatitis Treatment (KeY Treat) Trial: A Model of Care in a Rural Appalachian County, U.S.
Dr. Jennifer R. Havens
Infectious disease epidemiologist and Professor in the Department of Behavioral Science, University of Kentucky College of Medicine (UKCOM), USA

Antimicrobial resistance, an update from the Middle East
Dr. Mohammed Al Zunitan
Deputy Executive Director, Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, KSA

Impact of Carbapenems-PCR in MRE-Outbreak-Management - cost vs. benefit
PD Dr. Thomas Bollinger
Institute Director, Specialist in Microbiology, Virology and Infection Epidemiology Specialist Immunologist, Deutschen Gesellschaft für Immunologie (DGFI), GermanyIn booth sessions